Physician profile
Dalkeith Facey
NPI 1568754323
$2,645.12
in general payments reported to CMS, 2019-2025
12 companies · $59.29 in 2025
The $59.29 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.55 · 2021: $106 · 2022: $798 · 2023: $277 · 2024: $1,375 · 2025: $59.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Travel and Lodging: $791 · Gift: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.62 |
| Travel and Lodging | $791.20 |
| Gift | $104.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,648.15 | 2022-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $706.63 | 2022 | |
| Allergan, INC. | $53.85 | 2019-2022 | |
| Boston Scientific Corporation | $47.90 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Integra Lifesciences Corporation | $42.20 | 2022 | |
| Ethicon US, LLC | $38.53 | 2021 | |
| Kerecis Limited | $26.61 | 2021 | |
| Solventum Corporation | $24.08 | 2025 | V.A.C.Ulta, Prevena |
| Innocoll Pharmaceuticals Limited | $17.80 | 2021 | |
| Tela Bio, INC. | $14.77 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $13.23 | 2022 | |
| Leica Microsystems INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalkeith Facey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.